NETEC Resource Library

Search Instructions:

* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Search (686 total)

  • Query: COVID
  • Query type: Keyword
  • Record types:
    • Item
    • Exhibit
    • Simple Page
Record Type Title Thumbnail Subject Date Published Description
Item Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial Treatment & Care 2022-05-23 Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to mechanical ventilation or death in hospitalised patients…
Item Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Research 2020-03-26 A cluster of patients with coronavirus disease 2019 (COVID-19) pneumonia caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were successively reported in Wuhan, China.Read a response to this article here: Huang, Yongshun, Weibin Cheng, Na Zhao, Hongying Qu, and…
Item The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Research 2020-03-10 A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019.
Item Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 Research 2020-05-01 A potential association between the use of angiotensin-receptor blockers (ARBs) and angiotensin-converting–enzyme (ACE) inhibitors and the risk of coronavirus disease 2019 (Covid-19) has not been well studied.
Item hide_me.png Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 Research 2020-06-18 Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use.
Item COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Research 2020-07-14 Several countries affected by the COVID-19 pandemic have reported a substantial drop in the number of patients attending the emergency department with acute coronary syndromes and a reduced number of cardiac procedures. We aimed to understand the scale, nature, and duration of changes to admissions…
Item COVID-19 and multisystem inflammatory syndrome in children and adolescents Research 2020-08-17 As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there have been increasing reports from Europe, North America, Asia, and Latin America describing children and adolescents with COVID-19-associated multisystem inflammatory conditions.A response to this article was…
Item Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients Research 2020-06-23 SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection.
Item The role of dedicated biocontainment patient care units in preparing for COVID-19 and other infectious disease outbreaks Physical Infrastructure 2020-09-04 In response to the Ebola outbreak of 2014-2016, the US Office of the Assistant Secretary for Preparedness and Response (ASPR) established 10 regional treatment centers, called biocontainment units (BCUs) to prepare and provide care for patients infected with high consequence pathogens. Many of these…

Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

Item SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study Research 2020-11-02 The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear.